Abstract
Intrahepatic cholangiocarcinoma (IHCC) poses a significant clinical challenge due to its aggressive nature and high recurrence rates following surgery. Despite being the second most common primary liver tumor, optimal management strategies remain elusive. The role of lymphadenectomy in IHCC remains a subject of debate, with conflicting evidence regarding its impact on survival outcomes. This article provides a comprehensive overview of the latest recommendations and controversies surrounding lymphadenectomy in IHCC. It highlights the importance of accurate disease staging and discusses the potential benefits of lymphadenectomy. Additionally, the article emphasizes the significance of staging laparoscopy and intraoperative ultrasound in enhancing the detection of metastatic lesions and guiding surgical decision-making. Drawing from current guidelines and clinical studies, this article is aimed at providing valuable insights into the optimal lymphadenectomy in IHCC, ultimately contributing to improved patient outcomes.